Your browser doesn't support javascript.
loading
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.
Wang, Ying; He, Shan; Calendo, Gennaro; Bui, Tien; Tian, Yuanyuan; Lee, Che Young; Zhou, Yan; Zhao, Xin; Abraham, Ciril; Mo, Wenbin; Chen, Mimi; Sanders-Braggs, Ruqayyah; Madzo, Jozef; Issa, Jean-Pierre; Hexner, Elizabeth O; Wiest, David L; Reshef, Ran; Xue, Hai-Hui; Zhang, Yi.
Afiliação
  • Wang Y; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • He S; Fels Institute and Department of Cancer Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
  • Calendo G; Coriell Institute for Medical Research, Camden, NJ.
  • Bui T; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Tian Y; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Lee CY; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Zhou Y; Fox Chase Cancer Center, Temple University, Philadelphia, PA.
  • Zhao X; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Abraham C; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Mo W; Fels Institute and Department of Cancer Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
  • Chen M; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Sanders-Braggs R; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Madzo J; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
  • Issa JP; Coriell Institute for Medical Research, Camden, NJ.
  • Hexner EO; Coriell Institute for Medical Research, Camden, NJ.
  • Wiest DL; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Reshef R; Fox Chase Cancer Center, Temple University, Philadelphia, PA.
  • Xue HH; Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY.
  • Zhang Y; Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ.
Blood ; 143(2): 166-177, 2024 Jan 11.
Article em En | MEDLINE | ID: mdl-37871574
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Doença Enxerto-Hospedeiro Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Doença Enxerto-Hospedeiro Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article